文献速递妇科

宫颈癌根治性子宫切除术在微创入路宫颈癌试验后的实践模式与并发症

Practice patterns and complications of hysterectomy for invasive cervical cancer after the Laparoscopic Approach to Cervical Cancer trial.
PubMed 文献 · Am J Obstet Gynecol · 2023-09-09

基于美国外科医师学会国家手术质量改进计划数据,比较微创入路宫颈癌试验发表前后(2016年1月至2017年12月 vs 2019年1月至2020年12月)浸润性宫颈癌子宫切除术的术式变化及30天并发症。微创率从75.6%降至41.1%,开腹率从24.4%升至58.9%(P<.001);30天主要并发症、次要并发症及非计划再入院无显著变化,但输血率从3.8%升至6.7%(调整OR 1.79,95%CI 1.27-2.53)。

要点

  • 微创入路宫颈癌试验发表后,微创子宫切除术率从75.6%降至41.1%,开腹率从24.4%升至58.9%(P<.001)。
  • 30天主要并发症(5.6% vs 4.9%,调整OR 0.85,95%CI 0.61-1.17)与次要并发症(6.8% vs 8.0%,调整OR 1.17,95%CI 0.89-1.55)无显著变化。
  • 输血率从3.8%升至6.7%(调整OR 1.79,95%CI 1.27-2.53),非计划再入院率无显著变化(调整HR 0.78,95%CI 0.58-1.04)。

核心结论

  • 微创入路宫颈癌试验发表后,浸润性宫颈癌的术式由微创向开腹显著转变,30天主要并发症、次要并发症及非计划再入院率未增加,但输血率增加。

研究设计与样本

  • 基于美国外科医师学会国家手术质量改进计划数据的比较研究,纳入3024例接受开腹或微创子宫切除术的浸润性宫颈癌患者。
  • 比较微创入路宫颈癌试验发表前(2016年1月至2017年12月,1515例,50.1%)与发表后(2019年1月至2020年12月,1509例,49.9%)两个时期。

主要发现

  • 微创率从发表前75.6%(1145/1515)降至发表后41.1%(620/1509),开腹率从24.4%(370/1515)升至58.9%(889/1509)(P<.001)。
  • 30天主要并发症发表前85/1515(5.6%)vs 发表后74/1509(4.9%)(调整OR 0.85,95%CI 0.61-1.17)。
  • 30天次要并发症发表前103/1515(6.8%)vs 发表后120/1509(8.0%)(调整OR 1.17,95%CI 0.89-1.55)。
  • 非计划再入院率发表前7.9%/30人日 vs 发表后6.3%/30人日(调整HR 0.78,95%CI 0.58-1.04)。
  • 输血率从发表前3.8%(58/1515)升至发表后6.7%(101/1509)(调整OR 1.79,95%CI 1.27-2.53)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: After the publication of the Laparoscopic Approach to Cervical Cancer trial, the standard surgical approach for early-stage cervical cancer is open radical hysterectomy. Only limited data were available regarding whether the change to open abdominal hysterectomy observed after the Laparoscopic Approach to Cervical Cancer trial led to an increase in postoperative complication rates as a consequence of the decrease in the use of the minimally invasive approach. OBJECTIVE: This study aimed to analyze whether there was a correlation between the publication of the Laparoscopic Approach to Cervical Cancer trial and an increase in the 30-day complications associated with surgical treatment of invasive cervical cancer. STUDY DESIGN: Data from the American College of Surgeons National Surgical Quality Improvement Program were used to compare the results in the pre-Laparoscopic Approach to Cervical Cancer period (January 2016 to December 2017) vs the results in the post-Laparoscopic Approach to Cervical Cancer period (January 2019 to December 2020). The rates of each surgical approach (open abdominal or minimally invasive) hysterectomy for invasive cervical cancer during the 2 periods were assessed. Subsequently, 30-day major complication, minor complication, unplanned hospital readmission, and intra- or postoperative transfusion rates before and after the publication of the Laparoscopic Approach to Cervical Cancer trial were compared. RESULTS: Overall, 3024 patients undergoing either open abdominal hysterectomy or minimally invasive hysterectomy for invasive cervical cancer were included in the study. Of the patients, 1515 (50.1%) were treated in the pre-Laparoscopic Approach to Cervical Cancer period, and 1509 (49.9%) were treated in the post-Laparoscopic Approach to Cervical Cancer period. The rate of minimally invasive approaches decreased significantly from 75.6% (1145/1515) in the pre-Laparoscopic Approach to Cervical Cancer period to 41.1% (620/1509) in the post-Laparoscopic Approach to Cervical Cancer period, whereas the rate of open abdominal approach increased from 24.4% (370/1515) in the pre-Laparoscopic Approach to Cervical Cancer period to 58.9% (889/1509) in the post-Laparoscopic Approach to Cervical Cancer period (P<.001). The overall 30-day major complications remained stable between the pre-Laparoscopic Approach to Cervical Cancer period (85/1515 [5.6%]) and the post-Laparoscopic Approach to Cervical Cancer period (74/1509 [4.9%]) (adjusted odds ratio, 0.85; 95% confidence interval, 0.61-1.17). The overall 30-day minor complications were similar in the pre-Laparoscopic Approach to Cervical Cancer period (103/1515 [6.8%]) vs the post-Laparoscopic Approach to Cervical Cancer period (120/1509 [8.0%]) (adjusted odds ratio, 1.17; 95% confidence interval, 0.89-1.55). The unplanned hospital readmission rate remained stable during the pre-Laparoscopic Approach to Cervical Cancer period (7.9% per 30 person-days) and during the post-Laparoscopic Approach to Cervical Cancer period (6.3% per 30 person-days) (adjusted hazard ratio, 0.78; 95% confidence interval, 0.58-1.04)]. The intra- and postoperative transfusion rates increased significantly from 3.8% (58/1515) in the pre-Laparoscopic Approach to Cervical Cancer period to 6.7% (101/1509) in the post-Laparoscopic Approach to Cervical Cancer period (adjusted odds ratio, 1.79; 95% confidence interval, 1.27-2.53). CONCLUSION: This study observed a significant shift in the surgical approach for invasive cervical cancer after the publication of the Laparoscopic Approach to Cervical Cancer trial, with a reduction in the minimally invasive abdominal approach and an increase in the open abdominal approach. The change in surgical approach was not associated with an increase in the rate of 30-day major or minor complications and unplanned hospital readmission, although it was associated with an increase in the transfusion rate.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Schivardi G, Casarin J, Habermann EB, et al. Practice patterns and complications of hysterectomy for invasive cervical cancer after the Laparoscopic Approach to Cervical Cancer trial. Am J Obstet Gynecol. 2023. PMID: 37690596. doi:10.1016/j.ajog.2023.09.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。